Literature DB >> 25555349

Mechanism of subunit coordination of an AAA+ hexameric molecular nanomachine.

Xian Jessica Yu1, William B Greenleaf1, Yemin Stanley Shi1, Xiaojiang S Chen2.   

Abstract

Simian virus 40 large tumor antigen (LT) is both a potent oncogenic protein and an efficient hexameric nanomachine that harnesses the energy from ATP binding/hydrolysis to melt origin DNA and unwind replication forks. However, how the six subunits of the helicase motor coordinate during ATP hydrolysis and DNA unwinding/translocation is unresolved. Here we investigated the subunit coordination mechanisms "binomial distribution mutant doping" experiments in the presence of various DNA substrates. For ATP hydrolysis, we observed multiple coordination modes, ranging from random and semi-random, and semi-coordinated modes, depending on which type of DNA is present. For DNA unwinding, however, the results indicated a fully-coordinated mode for the natural origin-containing duplex DNA, but a semi-coordinated mode for a pre-existing fork-DNA, providing direct evidence for LT to use potentially different mechanisms to unwind the two types of substrates. The results of this study provide insights into DNA translocation and unwinding mechanisms for LT hexameric biomotor. From the clinical editor: The study describes the subunit coordination of simian virus 40 large tumor antigen (LT) showing that multiple mechanisms exist that handle the specific needs of different stages of DNA replication.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP hydrolysis mode; Hexameric nanomachine; Origin DNA unwinding; Replicative helicase; Substrate-dependent subunit coordination

Mesh:

Substances:

Year:  2014        PMID: 25555349     DOI: 10.1016/j.nano.2014.11.005

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  1 in total

1.  Study of SV40 large T antigen nucleotide specificity for DNA unwinding.

Authors:  Damian Wang; Ana Lucia Álvarez-Cabrera; Xiaojiang S Chen
Journal:  Virol J       Date:  2017-04-14       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.